Metcela fetches $12.7m Series B
Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.
Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination